U2AF1 and lung cancer: Surprisingly, while U2AF1 mutations have been observed in ~3% of lung adenocarcinomas (LUAD), their frequency in other lung cancer subtypes appears to be lower, including in squamous cell carcinomas (LUSC)34,35 and small cell carcinomas (SCLC)36.